Search Results for: macular degeneration

The anti-cure movement continues attacks on stem cell research, this time in Missouri

The opponents of hope, those anti-cure crusaders, will not give up and they are active on both the state and federal levels. Today we heard from the S. Louis Beacon that “Missouri Roundtable for Life” is aiming for a 2012 ballot initiative to change the definition of human cloning in such a way that some forms

The anti-cure movement continues attacks on stem cell research, this time in Missouri Read More »

Advanced Cell Technology and Geron: allies or competitors?

Geron-300x2212

Two companies, Advanced Cell Technology (ACT) and Geron, both HQ’d here in California, have FDA-approved early stage clinical trials in the works. Geron’s trial has already started and reportedly now has enrolled at least two patients. The trial is of course for the safety of Geron’s GRNOPC1 oligodendrocyte product made from human ES cells for

Advanced Cell Technology and Geron: allies or competitors? Read More »

FDA approves ACT’s second stem cell trial for blindness

Advanced Cell Technology (ACT) announced that the FDA has approved their second human ES cell-based clinical trial, a combined Phase I/II, for the treatment of blindness. As a result, soon ACT will have two active, human ES cell-based clinical trials, both using the same human ES cell-based drug. The aim of the 2nd trial is

FDA approves ACT’s second stem cell trial for blindness Read More »

TV Journalists Tackling Stem Cell Clinics

CBS-This-Morning-TV-segment-Stem-Cells

Even as some unproven, for-profit stem cell clinics promote themselves aggressively in many ways including now on TV, on the flip side lately we’ve seen more TV journalists covering questionable marketing by the clinics and negative patient outcomes. Today I saw that CBS This Morning, a national broadcast, had a fairly long TV segment on stem

TV Journalists Tackling Stem Cell Clinics Read More »

Great news: FDA gives ACT the green light bringing hope to millions of people with blindness

advanced-cell-technology

The FDA has given Advanced Cell Technology (ACT) the go ahead to begin their clinical trial using retinal progenitor cells derived from hESC by clearing the company’s IND application, bringing hope to those with vision loss and even blindness. The trial will be a combined Phase I/II to treat Stargardt’s Macular Dystrophy and has huge

Great news: FDA gives ACT the green light bringing hope to millions of people with blindness Read More »